106 related articles for article (PubMed ID: 22362698)
1. Co-trimoxazole-induced myopia in an HIV-positive patient.
Kamath S; Acharya N; Nithyanandam S
Int J STD AIDS; 2012 Jan; 23(1):71-2. PubMed ID: 22362698
[TBL] [Abstract][Full Text] [Related]
2. Co-trimoxazole prophylaxis in HIV: the evidence.
Young T; Oliphant CE; Araoyinbo I; Volmink J
S Afr Med J; 2008 Apr; 98(4):258-9. PubMed ID: 18637628
[No Abstract] [Full Text] [Related]
3. [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine].
Koch A; Kothe H; Braun J; Kämmerer R; Friedrich HJ; Dalhoff K
Pneumologie; 1998 Nov; 52(11):614-21. PubMed ID: 9885511
[TBL] [Abstract][Full Text] [Related]
4. Mild rhabdomyolysis after high-dose trimethoprim-sulfamethoxazole in a patient with HIV infection.
Anders HJ; Bogner JR; Goebel FD
Eur J Med Res; 1997 May; 2(5):198-200. PubMed ID: 9153343
[TBL] [Abstract][Full Text] [Related]
5. Severe hyponatraemia and severe hyperkalaemia in an HIV positive patient who received high dose co-trimoxazole.
David LM; Ross J
Sex Transm Infect; 1998 Feb; 74(1):75-6. PubMed ID: 9634313
[No Abstract] [Full Text] [Related]
6. Desensitization to co-trimoxazole in a patient with fixed drug eruption.
Patriarca G; Schiavino D; Buonomo A; Aruanno A; Altomonte G; Nucera E
J Investig Allergol Clin Immunol; 2008; 18(4):309-11. PubMed ID: 18714541
[TBL] [Abstract][Full Text] [Related]
7. Consensus on use of co-trimoxazole.
Trop Doct; 2001 Jul; 31(3):189-90. PubMed ID: 11444358
[No Abstract] [Full Text] [Related]
8. Co-trimoxazole prophylaxis in tropical countries in the era of highly active antiretroviral therapy: do we know enough?
Lynen L; Jacobs J; Colebunders R
Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1059-60. PubMed ID: 17662321
[TBL] [Abstract][Full Text] [Related]
9. Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
Ribera E; Fernandez-Sola A; Juste C; Rovira A; Romero FJ; Armadans-Gil L; Ruiz I; Ocaña I; Pahissa A
Clin Infect Dis; 1999 Dec; 29(6):1461-6. PubMed ID: 10585796
[TBL] [Abstract][Full Text] [Related]
10. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
[TBL] [Abstract][Full Text] [Related]
11. Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries.
Zachariah R; Harries AD; Luo C; Bachman G; Graham SM
Lancet Infect Dis; 2007 Oct; 7(10):686-93. PubMed ID: 17897611
[TBL] [Abstract][Full Text] [Related]
12. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
Chintu C; Bhat GJ; Walker AS; Mulenga V; Sinyinza F; Lishimpi K; Farrelly L; Kaganson N; Zumla A; Gillespie SH; Nunn AJ; Gibb DM;
Lancet; 2004 Nov 20-26; 364(9448):1865-71. PubMed ID: 15555666
[TBL] [Abstract][Full Text] [Related]
13. Co-trimoxazole in HIV-1 infection.
Brindle R
Lancet; 1999 Jul; 354(9175):333-4; author reply 335. PubMed ID: 10440329
[No Abstract] [Full Text] [Related]
14. Co-trimoxazole in HIV-1 infection.
Hudson CP; Roach T
Lancet; 1999 Jul; 354(9175):333; author reply 335. PubMed ID: 10440328
[No Abstract] [Full Text] [Related]
15. Randomised, placebo-controlled trial to evaluate co-trimoxazole to reduce mortality and morbidity in HIV-infected post-natal women in Zambia (TOPAZ).
Nunn AJ; Mwaba PB; Chintu C; Crook AM; Darbyshire JH; Ahmed Y; Zumla AI
Trop Med Int Health; 2011 Apr; 16(4):518-26. PubMed ID: 21281407
[TBL] [Abstract][Full Text] [Related]
16. Is it necessary to conduct trials with trimethoprim-sulphamethoxazole amongst HIV-infected individuals in Africa?
Samb B; Badiane M; Kony S; Larouzé B; Faye MA; Sow PS; Badiane S; Metro A; Costagliola D; Ndoye I; Delaporte E; Coll-Seck AM; Coulaud JP
AIDS; 1998 Mar; 12(4):447. PubMed ID: 9520181
[No Abstract] [Full Text] [Related]
17. Co-trimoxazole in HIV-1 infection.
Boeree MJ; Harries AD; Zijlstra EE; Taylor TE; Molyneux ME
Lancet; 1999 Jul; 354(9175):334; author reply 335. PubMed ID: 10440330
[No Abstract] [Full Text] [Related]
18. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.
Mermin J; Lule J; Ekwaru JP; Malamba S; Downing R; Ransom R; Kaharuza F; Culver D; Kizito F; Bunnell R; Kigozi A; Nakanjako D; Wafula W; Quick R
Lancet; 2004 Oct 16-22; 364(9443):1428-34. PubMed ID: 15488218
[TBL] [Abstract][Full Text] [Related]
19. Co-trimoxazole in HIV-1 infection.
Badri M; Maartens G; Wood R; Ehrlich R
Lancet; 1999 Jul; 354(9175):334-5. PubMed ID: 10440331
[No Abstract] [Full Text] [Related]
20. Familial tendency in hypersensitivity reactions to co-trimoxazole.
Mohanasundaram J; Rajaram S; Mohanasundaram S
J Indian Med Assoc; 1998 Jan; 96(1):21-2. PubMed ID: 9601187
[No Abstract] [Full Text] [Related]
[Next] [New Search]
